These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 23223134)
1. Loss of extracellular superoxide dismutase induces severe IL-23-mediated skin inflammation in mice. Lee YS; Cheon IS; Kim BH; Kwon MJ; Lee HW; Kim TY J Invest Dermatol; 2013 Mar; 133(3):732-741. PubMed ID: 23223134 [TBL] [Abstract][Full Text] [Related]
2. A Toll-like receptor 7, 8, and 9 antagonist inhibits Th1 and Th17 responses and inflammasome activation in a model of IL-23-induced psoriasis. Jiang W; Zhu FG; Bhagat L; Yu D; Tang JX; Kandimalla ER; La Monica N; Agrawal S J Invest Dermatol; 2013 Jul; 133(7):1777-84. PubMed ID: 23370539 [TBL] [Abstract][Full Text] [Related]
4. Enhancement of collagen-induced arthritis in mice genetically deficient in extracellular superoxide dismutase. Ross AD; Banda NK; Muggli M; Arend WP Arthritis Rheum; 2004 Nov; 50(11):3702-11. PubMed ID: 15529385 [TBL] [Abstract][Full Text] [Related]
5. Regulation of skin inflammation and angiogenesis by EC-SOD via HIF-1α and NF-κB pathways. Kim Y; Kim BH; Lee H; Jeon B; Lee YS; Kwon MJ; Kim TY Free Radic Biol Med; 2011 Dec; 51(11):1985-95. PubMed ID: 21925591 [TBL] [Abstract][Full Text] [Related]
6. EC-SOD suppresses contact hypersensitivity in mouse skin by impairing Langerhans cell migration. Na K; Kim KE; Park ST; Kim TY J Invest Dermatol; 2007 Aug; 127(8):1930-7. PubMed ID: 17392825 [TBL] [Abstract][Full Text] [Related]
7. Suppression of IL-23-mediated psoriasis-like inflammation by regulatory B cells. Mizumaki K; Horii M; Kano M; Komuro A; Matsushita T Sci Rep; 2021 Jan; 11(1):2106. PubMed ID: 33483537 [TBL] [Abstract][Full Text] [Related]
8. Extracellular superoxide dismutase ameliorates house dust mite-induced atopic dermatitis-like skin inflammation and inhibits mast cell activation in mice. Lee YS; Choi JH; Lee JH; Lee HW; Lee W; Kim WT; Kim TY Exp Dermatol; 2016 Aug; 25(8):630-5. PubMed ID: 27061078 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory Effect of Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice by Histamine H4 Receptor Agonist 4-Methylhistamine. Kim CH; Lee JM; Yoo JK; Kim JS; Kim SU; Chang KT; Choo YK Scand J Immunol; 2016 Jun; 83(6):409-17. PubMed ID: 26900758 [TBL] [Abstract][Full Text] [Related]
15. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Ha HY; Kim Y; Ryoo ZY; Kim TY Biochem Biophys Res Commun; 2006 Sep; 348(2):450-8. PubMed ID: 16890203 [TBL] [Abstract][Full Text] [Related]
17. Effects of Human Mesenchymal Stem Cells Transduced with Superoxide Dismutase on Imiquimod-Induced Psoriasis-Like Skin Inflammation in Mice. Sah SK; Park KH; Yun CO; Kang KS; Kim TY Antioxid Redox Signal; 2016 Feb; 24(5):233-48. PubMed ID: 26462411 [TBL] [Abstract][Full Text] [Related]
18. IL-23-mediated psoriasis-like epidermal hyperplasia is dependent on IL-17A. Rizzo HL; Kagami S; Phillips KG; Kurtz SE; Jacques SL; Blauvelt A J Immunol; 2011 Feb; 186(3):1495-502. PubMed ID: 21172868 [TBL] [Abstract][Full Text] [Related]
19. Interleukin (IL)-18, cooperatively with IL-23, induces prominent inflammation and enhances psoriasis-like epidermal hyperplasia. Shimoura N; Nagai H; Fujiwara S; Jimbo H; Yoshimoto T; Nishigori C Arch Dermatol Res; 2017 May; 309(4):315-321. PubMed ID: 28299442 [TBL] [Abstract][Full Text] [Related]
20. Activation of Langerhans cells promotes the inflammation in imiquimod-induced psoriasis-like dermatitis. Xiao C; Zhu Z; Sun S; Gao J; Fu M; Liu Y; Wang G; Yao X; Li W J Dermatol Sci; 2017 Mar; 85(3):170-177. PubMed ID: 27964879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]